The Limitations of Artificial Intelligence in Head and Neck Oncology

IF 3.4 3区医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL

Advances in Therapy Pub Date : 2025-04-29 DOI:10.1007/s12325-025-03198-4

Karthik N. Rao, Veronica Fernandez-Alvarez, Orlando Guntinas-Lichius, M. P. Sreeram, Remco de Bree, Luiz P. Kowalski, Arlene Forastiere, Pia Pace-Asciak, Juan P. Rodrigo, Nabil F. Saba, Ohad Ronen, Ewa Florek, Gregory W. Randolph, Alvaro Sanabria, Jan B. Vermorken, Ehab Y. Hanna, Alfio Ferlito

{"title":"The Limitations of Artificial Intelligence in Head and Neck Oncology","authors":"Karthik N. Rao, Veronica Fernandez-Alvarez, Orlando Guntinas-Lichius, M. P. Sreeram, Remco de Bree, Luiz P. Kowalski, Arlene Forastiere, Pia Pace-Asciak, Juan P. Rodrigo, Nabil F. Saba, Ohad Ronen, Ewa Florek, Gregory W. Randolph, Alvaro Sanabria, Jan B. Vermorken, Ehab Y. Hanna, Alfio Ferlito","doi":"10.1007/s12325-025-03198-4","DOIUrl":null,"url":null,"abstract":"<div><p>Artificial intelligence (AI) is revolutionizing head and neck oncology, offering innovations in tumor detection, treatment planning, and patient management. However, its integration into clinical practice is hindered by several limitations. These include clinician mistrust due to a lack of understanding of AI mechanisms, biases in algorithm development, and the potential over-reliance on technology, which may undermine clinical expertise. Data-related challenges, such as inconsistent quality and limited representativeness of datasets, further complicate AI’s application. Ethical, legal, and privacy concerns also pose significant barriers. Addressing these issues through transparent AI systems, clinician education, and clear regulations is essential for ensuring responsible, equitable use in head and neck oncology. This manuscript explores the limitations of AI in head and neck oncology.</p></div>","PeriodicalId":7482,"journal":{"name":"Advances in Therapy","volume":"42 6","pages":"2559 - 2568"},"PeriodicalIF":3.4000,"publicationDate":"2025-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s12325-025-03198-4.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in Therapy","FirstCategoryId":"3","ListUrlMain":"https://link.springer.com/article/10.1007/s12325-025-03198-4","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}

引用次数: 0

Abstract

Artificial intelligence (AI) is revolutionizing head and neck oncology, offering innovations in tumor detection, treatment planning, and patient management. However, its integration into clinical practice is hindered by several limitations. These include clinician mistrust due to a lack of understanding of AI mechanisms, biases in algorithm development, and the potential over-reliance on technology, which may undermine clinical expertise. Data-related challenges, such as inconsistent quality and limited representativeness of datasets, further complicate AI’s application. Ethical, legal, and privacy concerns also pose significant barriers. Addressing these issues through transparent AI systems, clinician education, and clear regulations is essential for ensuring responsible, equitable use in head and neck oncology. This manuscript explores the limitations of AI in head and neck oncology.

查看原文本刊更多论文

人工智能在头颈部肿瘤学中的局限性。

人工智能（AI）正在彻底改变头颈部肿瘤学，在肿瘤检测、治疗计划和患者管理方面提供创新。然而，其融入临床实践受到一些限制的阻碍。其中包括由于缺乏对人工智能机制的理解而导致的临床医生的不信任，算法开发中的偏见，以及可能破坏临床专业知识的潜在过度依赖技术。与数据相关的挑战，如数据集质量不一致和代表性有限，使人工智能的应用进一步复杂化。道德、法律和隐私问题也构成了重大障碍。通过透明的人工智能系统、临床医生教育和明确的法规来解决这些问题，对于确保头颈部肿瘤中负责任、公平的使用至关重要。本文探讨了人工智能在头颈部肿瘤中的局限性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Advances in Therapy 医学-药学

CiteScore

7.20

自引率

2.60%

发文量

353

审稿时长

6-12 weeks

期刊介绍： Advances in Therapy is an international, peer reviewed, rapid-publication (peer review in 2 weeks, published 3–4 weeks from acceptance) journal dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of therapeutics and interventions (including devices) across all therapeutic areas. Studies relating to diagnostics and diagnosis, pharmacoeconomics, public health, epidemiology, quality of life, and patient care, management, and education are also encouraged. The journal is of interest to a broad audience of healthcare professionals and publishes original research, reviews, communications and letters. The journal is read by a global audience and receives submissions from all over the world. Advances in Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of all scientifically and ethically sound research.